Notebook

Rejection Rate Rises at NIH Bromley Bids Farewell to Sununu Good Swaps Science Advisory Post Kassirer Won't Play the Name Game Stick to Politics and Religion Congress thinks that NIH's peer reviewers, who in 1990 rejected only 5 percent of the proposals they judged as members of NIH study sections, are too easy on scientists, and last year they asked NIH to do something about it. So last fall, as part of a broader series of changes in the peer review system, NIH created a new category-

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Congress thinks that NIH's peer reviewers, who in 1990 rejected only 5 percent of the proposals they judged as members of NIH study sections, are too easy on scientists, and last year they asked NIH to do something about it. So last fall, as part of a broader series of changes in the peer review system, NIH created a new category--"not recommended for further consideration"--and told study sections to apply it to applications that reviewers felt did not make the grade. Preliminary results show that it's working: After the first round of study section meetings, some 15 percent of proposals are falling into the new category. That leaves NIH officials with a slightly smaller pool from which to make awards (only about one-third of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies